A rare case: Spontaneous subdural hematoma in dengue hemorrhagic fever
Abstract
Background: Dengue hemorrhagic fever (DHF) is caused by dengue virus infection. Complications of this disease can include neurological disorders in the form of intracranial hemorrhage (ICH), although neurological complications of dengue are infrequent, with an incidence below 1%. ICH, a manifestation of dengue complications, has been reported, including subdural hematoma (SDH). It has limited management guidelines and has a poor prognosis.
Case description: A 52-year-old man presented to the emergency department with a sudden loss of consciousness 1 h prior, preceded by a severe headache, nausea, and multiple episodes of vomiting the previous day. He was hospitalized 5 days earlier for DHF with a platelet count of 30,000/μL; he was discharged on day four. On admission, the patient was unresponsive with a fever (38.6°C), hypertension (160/90 mmHg), and a Glasgow Coma Scale of 3/15. Neurological examination revealed anisocoria with absent light reflexes. Laboratory results showed thrombocytopenia (74,000/μL) with otherwise normal hematological, coagulation, and renal parameters. Non-contrast head computed tomography demonstrated a large right frontotemporoparietal subacute SDH with midline shift and cerebral edema.
Conclusion: Dengue infection can progress from mild illness to severe disease with serious complications, including rare but potentially fatal ICH, such as SDH. These neurological complications are mainly related to severe thrombocytopenia, coagulation disorders,…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.